Literature DB >> 31504571

Klebsiella pneumoniae and Klebsiella quasipneumoniae define the population structure of blaKPC-2Klebsiella: a 5 year retrospective genomic study in Singapore.

Sophie Octavia1, Marimuthu Kalisvar2,3,4, Indumathi Venkatachalam5, Oon Tek Ng2,3,6, Weizhen Xu2, Prakki Sai Rama Sridatta2, Yi Fa Ong2, Liang De Wang2, Amanda Chua2, Bernadette Cheng7, Raymond T P Lin1,7, Jeanette W P Teo7.   

Abstract

OBJECTIVES: To describe the population structure, molecular epidemiology and genetic context of blaKPC-2-bearing Klebsiella pneumoniae.
METHODS: Isolates (n = 157) were retrospective, phenotypically carbapenem-resistant blaKPC-positive K. pneumoniae, collected from public hospitals. WGS was performed on the Illumina platform. Phylogenomic analysis, screening of resistance and virulence genes, and comparison of the genetic environment of blaKPC were carried out.
RESULTS: Based on core-tree phylogeny, 67.5% of the isolates were K. pneumoniae and the remainder comprised Klebsiella quasipneumoniae. No Klebsiella variicola strains were observed. Only a single K. pneumoniae carbapenemase (KPC) variant type, blaKPC-2, was seen. MLSTs were diverse and did not comprise the 'traditional' KPC clonal group (CG) 258. blaKPC-2 was associated with a non-Tn4401 element (NTE) in >99% of genomes. Screening for four key virulence loci: yersiniabactin (ybt), aerobactin (iuc), salmochelin (iro) and colibactin (clb) as well as ICEKp (virulence-associated integrative conjugative element of K. pneumoniae), revealed the lack of virulence factors and ICEKp within K. quasipneumoniae. Amongst the K. pneumoniae, there were 32 ybt+ isolates (32/106, 30.2%) and, of these, 8 isolates were also clb+ (7.5%). K. pneumoniae serotypes K1 and K2, the majority of capsular serotype seen in patients with invasive liver abscess syndrome, were detected at 4.5% (7/157).
CONCLUSIONS: Results suggest that dissemination of blaKPC-2 is driven by NTEKPC in non-ST258 isolates. The detection of blaKPC-2K. pneumoniae serotypes K1/K2 carrying virulence factors, albeit in low numbers, reflects the worrisome convergence of carbapenem resistance and hypervirulence in K. pneumoniae.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31504571     DOI: 10.1093/jac/dkz332

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Genomic characterization of an emerging blaKPC-2 carrying Enterobacteriaceae clinical isolates in Thailand.

Authors:  Anusak Kerdsin; Saowarat Deekae; Sunee Chayangsu; Rujirat Hatrongjit; Peechanika Chopjitt; Dan Takeuchi; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

2.  Distribution of β-Lactamase Genes and Genetic Context of bla KPC-2 in Clinical Carbapenemase-Producing Klebsiella pneumoniae Isolates.

Authors:  Hongmao Liu; Hailong Lin; Zhewei Sun; Xinyi Zhu; Xueya Zhang; Qiaoling Li; Junwan Lu; Xi Lin; Li Lin; Kewei Li; Mei Zhu; Qiyu Bao; Teng Xu; Yunliang Hu; Hailin Zhang
Journal:  Infect Drug Resist       Date:  2021-01-26       Impact factor: 4.003

3.  Replicative transposition contributes to the evolution and dissemination of KPC-2-producing plasmid in Enterobacterales.

Authors:  Yu Tang; Gang Li; Pinghua Shen; Ying Zhang; Xiaofei Jiang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

4.  Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.

Authors:  Negin Bolourchi; Fereshteh Shahcheraghi; Christian G Giske; Shoeib Nematzadeh; Narjes Noori Goodarzi; Hamid Solgi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-10-23       Impact factor: 3.944

Review 5.  Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae.

Authors:  Yu-Ling Han; Xu-Hui Wen; Wen Zhao; Xi-Shan Cao; Jian-Xun Wen; Jun-Rui Wang; Zhi-De Hu; Wen-Qi Zheng
Journal:  Front Microbiol       Date:  2022-09-12       Impact factor: 6.064

6.  Analysis of a novel class A β-lactamase OKP-B-6 of Klebsiella quasipneumoniae: structural characterisation and interaction with commercially available drugs.

Authors:  Reinaldo Bellini; Isabella Alvim Guedes; Luciane Prioli Ciapina; Ana Tereza Ribeiro de Vasconcelos; Laurent Emmanuel Dardenne; Marisa Fabiana Nicolás
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-09-23       Impact factor: 2.747

7.  Genomic Characterization of Klebsiella quasipneumoniae from Clinical Specimens in Singapore.

Authors:  Ka Lip Chew; Sophie Octavia; Deborah Lai; Raymond T P Lin; Jeanette W P Teo
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 8.  Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

Authors:  Subhankar Mukherjee; Shravani Mitra; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2021-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.